Electrophysiological experiments have demonstrated that gain-of-function mutations in TRPV3 can exert significant pathogenic effects on protein function, leading to the characteristic pathological phenotype of Olmsted syndrome (OS) (7). The gene discussed is TRPV3; the disease is Olmsted syndrome 1.